Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Susan Bobulsky currently holds 406,288 shares of Adaptive Biotechnologies Corp (ADPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Bobulsky has been a net seller of ADPT stock. They have purchased $0 and sold $2.9M worth of shares.
Susan Bobulsky's most recent insider trade was on Jul 1, 2026, when they sold 487 shares at $22.00 per share.
Susan Bobulsky serves as Executive at Adaptive Biotechnologies Corp (ADPT). They have executed 15 insider transactions totaling $2.9M over their tenure at the company.
Susan Bobulsky holds the position of Executive at Adaptive Biotechnologies Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Susan Bobulsky has shown a selling trading pattern, with $0 in total purchases and $2.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Susan Bobulsky was on Dec 10, 2020, when they sold $1.4M worth of ADPT shares. This transaction involved 25,000 shares at $55.00 per share.
Susan Bobulsky currently owns 406,288 shares of Adaptive Biotechnologies Corp (ADPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Susan Bobulsky's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Susan Bobulsky has 15 Form 4 filings on record as an insider at Adaptive Biotechnologies Corp.
Set alerts for Susan Bobulsky and 40,000+ other insiders.